Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference newsletter

  Breast Cancer

  Free Subscription


1 AJR Am J Roentgenol
1 Ann Oncol
2 Ann Surg Oncol
1 Anticancer Res
1 BMC Cancer
3 Breast Cancer
1 Breast Cancer (Auckl)
7 Breast Cancer Res Treat
4 Breast J
1 Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Clin Breast Cancer
2 Clin Cancer Res
1 Clin Exp Metastasis
3 Eur Radiol
1 Int J Oncol
3 Int J Radiat Oncol Biol Phys
1 J Clin Invest
2 J Clin Oncol
3 J Natl Cancer Inst
2 Lancet
5 NPJ Breast Cancer
1 Oncogene
5 Oncol Rep
1 Oncology (Williston Park)
1 Pathology
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiother Oncol
1 Semin Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. CHIKARMANE SA, Cochon LR, Khorasani R, Sahu S, et al
    Screening Mammography Performance Metrics of 2D Digital Mammography Versus Digital Breast Tomosynthesis in Women With a Personal History of Breast Cancer.
    AJR Am J Roentgenol. 2020 Sep 23. doi: 10.2214/AJR.20.23976.
    PubMed         Abstract available

    Ann Oncol

  2. KALINSKY K, Diamond JR, Vahdat LT, Tolaney SM, et al
    Sacituzumab Govitecan in Previously Treated Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Final Results from a Phase 1/2, Single-Arm, Basket Trial.
    Ann Oncol. 2020 Sep 15. pii: S0923-7534(20)42445.
    PubMed         Abstract available

    Ann Surg Oncol

  3. TAMIRISA NP, Ren Y, Campbell BM, Thomas SM, et al
    Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.
    Ann Surg Oncol. 2020 Sep 18. pii: 10.1245/s10434-020-09024.
    PubMed         Abstract available

  4. BHUROSY T, Niu Z, Heckman CJ
    ASO Author Reflections: Is Breastfeeding Still Possible After Breast Cancer Treatment?
    Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09148.

    Anticancer Res

  5. NASIR UM, Mozeika AM, Sayan M, Jan I, et al
    Severe Gastrointestinal Mucositis Following Concurrent Palbociclib and Palliative Radiation Therapy.
    Anticancer Res. 2020;40:5291-5294.
    PubMed         Abstract available

    BMC Cancer

  6. NAWAS AF, Kanchwala M, Thomas-Jardin SE, Dahl H, et al
    IL-1-conferred gene expression pattern in ERalpha(+) BCa and AR(+) PCa cells is intrinsic to ERalpha(-) BCa and AR(-) PCa cells and promotes cell survival.
    BMC Cancer. 2020;20:46.
    PubMed         Abstract available


  7. ZHANG Y, Birmann BM, Han J, Giovannucci EL, et al
    Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study.
    BMJ. 2020;370:m2942.
    PubMed         Abstract available

    Breast Cancer

  8. AHMED M
    Optimizing breast cancer surgery during the COVID-19 pandemic.
    Breast Cancer. 2020 Sep 18. pii: 10.1007/s12282-020-01160.
    PubMed         Abstract available

  9. FUJII T, Ichiba K, Honda C, Tokuda S, et al
    Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
    Breast Cancer. 2020 Sep 17. pii: 10.1007/s12282-020-01161.
    PubMed         Abstract available

  10. ONISHI N, Kataoka M
    Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
    Breast Cancer. 2020 Sep 21. pii: 10.1007/s12282-020-01157.
    PubMed         Abstract available

    Breast Cancer (Auckl)

  11. ARECCO L, Perachino M, Damassi A, Latocca MM, et al
    Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.
    Breast Cancer (Auckl). 2020;14:1178223420954179.
    PubMed         Abstract available

    Breast Cancer Res Treat

  12. GEBREMARIAM A, Dereje N, Addissie A, Worku A, et al
    Factors associated with late-stage diagnosis of breast cancer among women in Addis Ababa, Ethiopia.
    Breast Cancer Res Treat. 2020 Sep 18. pii: 10.1007/s10549-020-05919.
    PubMed         Abstract available

  13. KONISHI T, Fujiogi M, Michihata N, Morita K, et al
    Association between body mass index and localization of breast cancer: results from a nationwide inpatient database in Japan.
    Breast Cancer Res Treat. 2020 Sep 19. pii: 10.1007/s10549-020-05934.
    PubMed         Abstract available

  14. JERZAK KJ, Lohmann AE, Ennis M, Nemeth E, et al
    Prognostic associations of plasma hepcidin in women with early breast cancer.
    Breast Cancer Res Treat. 2020 Sep 22. pii: 10.1007/s10549-020-05903.
    PubMed         Abstract available

  15. TIAINEN S, Rilla K, Hamalainen K, Oikari S, et al
    The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype.
    Breast Cancer Res Treat. 2020 Sep 18. pii: 10.1007/s10549-020-05925.
    PubMed         Abstract available

  16. JACOBSE JN, Schaapveld M, Boekel NB, Hooning MJ, et al
    Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
    Breast Cancer Res Treat. 2020 Sep 22. pii: 10.1007/s10549-020-05930.
    PubMed         Abstract available

  17. MARSH S, Borges VF, Coons HL, Afghahi A, et al
    Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers.
    Breast Cancer Res Treat. 2020 Sep 23. pii: 10.1007/s10549-020-05880.
    PubMed         Abstract available

  18. NICHOLS HB, Graff M, Bensen JT, Lunetta KL, et al
    Genetic variants in anti-Mullerian hormone-related genes and breast cancer risk: results from the AMBER consortium.
    Breast Cancer Res Treat. 2020 Sep 22. pii: 10.1007/s10549-020-05944.
    PubMed         Abstract available

    Breast J

  19. MA SJ, Oladeru OT, Singh AK
    Outcome of adjuvant chemotherapy in elderly patients with early-stage, hormone receptor-positive, HER-2-negative breast cancer.
    Breast J. 2020 Sep 18. doi: 10.1111/tbj.14054.
    PubMed         Abstract available

  20. WANG LC, Kuo CN, Ko Y
    Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan.
    Breast J. 2020 Sep 17. doi: 10.1111/tbj.14053.

  21. DESSIMONI M, Pessoa C, Filho B, Vespoli H, et al
    Breast density in Brazilian women and its risk for breast cancer and tumor aggressiveness.
    Breast J. 2020 Sep 20. doi: 10.1111/tbj.14042.

  22. CROWN A, Choi JH, Cole-Price A, Horowitz E, et al
    Optimizing care of breast cancer patients from low resource countries who immigrate to New York City: A case series from a large public hospital.
    Breast J. 2020 Sep 20. doi: 10.1111/tbj.14036.
    PubMed         Abstract available


  23. EMERSON MA, Golightly YM, Aiello AE, Reeder-Hayes KE, et al
    Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women.
    Cancer. 2020 Sep 21. doi: 10.1002/cncr.33121.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  24. XING CY, Doose M, Qin B, Lin Y, et al
    Prediagnostic Allostatic Load as a Predictor of Poorly Differentiated and Larger Sized Breast Cancers among Black Women in the Women's Circle of Health Follow-Up Study.
    Cancer Epidemiol Biomarkers Prev. 2020;29:216-224.
    PubMed         Abstract available

    Clin Breast Cancer

  25. JAMES J, Teo M, Ramachandran V, Law M, et al
    Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review.
    Clin Breast Cancer. 2020 Jul 8. pii: S1526-8209(20)30170.
    PubMed         Abstract available

    Clin Cancer Res

  26. PRAT A, Tsai YH, Pascual T, Pare L, et al
    A prognostic model based on PAM50 and clinical variables (PAM50MET) for metastatic hormone-receptor-positive HER2-negative breast cancer.
    Clin Cancer Res. 2020 Sep 22. pii: 1078-0432.CCR-20-2793.
    PubMed         Abstract available

  27. RICHARD F, Majjaj S, Venet D, Rothe F, et al
    Characterization of stromal tumor-infiltrating lymphocytes and genomic alterations in metastatic lobular breast cancer.
    Clin Cancer Res. 2020 Sep 17. pii: 1078-0432.CCR-20-2268.
    PubMed         Abstract available

    Clin Exp Metastasis

  28. HARTUNG F, Patil A, Meshram RJ, Weber GF, et al
    Gene expression signatures of site-specificity in cancer metastases.
    Clin Exp Metastasis. 2020;37:159-171.
    PubMed         Abstract available

    Eur Radiol

  29. BALTZER P, Mann RM, Iima M, Sigmund EE, et al
    Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.
    Eur Radiol. 2020;30:1436-1450.
    PubMed         Abstract available

  30. WENGERT GJ, Pipan F, Almohanna J, Bickel H, et al
    Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
    Eur Radiol. 2020;30:1451-1459.
    PubMed         Abstract available

  31. ARBOLEDA C, Wang Z, Jefimovs K, Koehler T, et al
    Towards clinical grating-interferometry mammography.
    Eur Radiol. 2020;30:1419-1425.
    PubMed         Abstract available

    Int J Oncol

  32. YANG WJ, Zhang GL, Cao KX, Liu XN, et al
    Heparanase from triplenegative breast cancer and platelets acts as an enhancer of metastasis.
    Int J Oncol. 2020 Aug 27. doi: 10.3892/ijo.2020.5115.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  33. KIM J, Chang JS, Lee DW, Song SY, et al
    In Regard to Naoum et al.
    Int J Radiat Oncol Biol Phys. 2020;107:223.

  34. LOAP P, Loirat D, Berger F, Ricci F, et al
    Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial.
    Int J Radiat Oncol Biol Phys. 2020 Sep 21. pii: S0360-3016(20)34304.
    PubMed         Abstract available

  35. NAOUM GE, Taghian AG
    In Reply to Kim et al.
    Int J Radiat Oncol Biol Phys. 2020;107:224.

    J Clin Invest

  36. SONG K, Cai X, Dong Y, Wu H, et al
    Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development.
    J Clin Invest. 2020 Sep 22. pii: 129374. doi: 10.1172/JCI129374.
    PubMed         Abstract available

    J Clin Oncol

  37. JOHNSTON SRD, Harbeck N, Hegg R, Toi M, et al
    Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
    J Clin Oncol. 2020 Sep 20:JCO2002514. doi: 10.1200/JCO.20.02514.
    PubMed         Abstract available

  38. WOLFF AC
    CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?
    J Clin Oncol. 2020 Sep 20:JCO2002688. doi: 10.1200/JCO.20.02688.

    J Natl Cancer Inst

  39. STRASSELS SA, Durham DD
    Re: Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast Cancer.
    J Natl Cancer Inst. 2020 Sep 21. pii: 5909658. doi: 10.1093.

  40. CHIARELLI AM, Blackmore KM, Mirea L, Done SJ, et al
    Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program.
    J Natl Cancer Inst. 2020;112:400-409.
    PubMed         Abstract available

  41. BARLOW WE, Beaber EF, Geller BM, Kamineni A, et al
    Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium.
    J Natl Cancer Inst. 2019 Jul 11. pii: 5530599. doi: 10.1093.
    PubMed         Abstract available


  42. MITTENDORF EA, Zhang H, Barrios CH, Saji S, et al
    Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3
    Lancet. 2020 Sep 18. pii: S0140-6736(20)31953.
    PubMed         Abstract available

    Advancing immunotherapy for early-stage triple-negative breast cancer.
    Lancet. 2020 Sep 18. pii: S0140-6736(20)31962.

    NPJ Breast Cancer

  44. MUSCARELLA AM, Dai W, Mitchell PG, Zhang W, et al
    Unique cellular protrusions mediate breast cancer cell migration by tethering to osteogenic cells.
    NPJ Breast Cancer. 2020;6:42.
    PubMed         Abstract available

  45. BODELON C, Oh H, Derkach A, Sampson JN, et al
    Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast.
    NPJ Breast Cancer. 2020;6:41.
    PubMed         Abstract available

  46. HE ZY, Lian CL, Wang J, Lei J, et al
    Incorporation of biologic factors for the staging of de novo stage IV breast cancer.
    NPJ Breast Cancer. 2020;6:43.
    PubMed         Abstract available

  47. MURANEN TA, Khan S, Fagerholm R, Aittomaki K, et al
    Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.
    NPJ Breast Cancer. 2020;6:44.
    PubMed         Abstract available

  48. GUERRERO LLOBET S, van der Vegt B, Jongeneel E, Bense RD, et al
    Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer.
    NPJ Breast Cancer. 2020;6:40.
    PubMed         Abstract available


  49. LI LY, Chen XS, Wang KS, Guan YD, et al
    RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKalpha2-mediated autophagy.
    Oncogene. 2020 Sep 21. pii: 10.1038/s41388-020-01447.
    PubMed         Abstract available

    Oncol Rep

  50. MENG L, Yue X, Zhou D, Li H, et al
    Long non coding RNA OIP5AS1 promotes metastasis of breast cancer via miR3405p/ZEB2 axis.
    Oncol Rep. 2020 Aug 10. doi: 10.3892/or.2020.7724.
    PubMed         Abstract available

  51. YU Y, He Y, Shao Y, Chen Q, et al
    lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR3405pdependent upregulation of SOX4.
    Oncol Rep. 2020 Jul 20. doi: 10.3892/or.2020.7699.
    PubMed         Abstract available

  52. ZHANG H, Wei N, Zhang W, Shen L, et al
    lncRNA SNHG3 promotes breast cancer progression by acting as a miR326 sponge.
    Oncol Rep. 2020 Jul 15. doi: 10.3892/or.2020.7690.
    PubMed         Abstract available

  53. YANG Z, Liu Z, Chang Z, Yan G, et al
    MicroRNA1885p inhibits the progression of breast cancer by targeting zinc finger protein 91.
    Oncol Rep. 2020 Aug 12. doi: 10.3892/or.2020.7731.
    PubMed         Abstract available

  54. HU Q, Yuan Y, Wu Y, Huang Y, et al
    MicroRNA137 exerts protective effects on hypoxiainduced cell injury by inhibiting autophagy/mitophagy and maintaining mitochondrial function in breast cancer stemlike cells.
    Oncol Rep. 2020 Aug 3. doi: 10.3892/or.2020.7714.
    PubMed         Abstract available

    Oncology (Williston Park)

  55. The Path to Improving Breast Cancer Outcomes.
    Oncology (Williston Park). 2020;34:358-360.
    PubMed         Abstract available


  56. RAZVI H, Tsang JY, Poon IK, Chan SK, et al
    INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Pathology. 2020 Sep 17. pii: S0031-3025(20)30888.
    PubMed         Abstract available

    PLoS One

  57. HONG S, Youk T, Lee SJ, Kim KM, et al
    Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    PLoS One. 2020;15:e0234927.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  58. ZERVANTONAKIS IK, Poskus MD, Scott AL, Selfors LM, et al
    Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.
    Proc Natl Acad Sci U S A. 2020;117:16500-16508.
    PubMed         Abstract available

    Radiother Oncol

  59. SONG J, Tang T, Caudrelier JM, Belec J, et al
    Dose-sparing effect of deep inspiration breath hold technique on coronary artery and left ventricle segments in treatment of breast cancer.
    Radiother Oncol. 2020 Sep 17. pii: S0167-8140(20)30792.
    PubMed         Abstract available

    Semin Oncol

  60. MCANDREW NP, Finn RS
    Management of ER positive metastatic breast cancer.
    Semin Oncol. 2020 Aug 29. pii: S0093-7754(20)30082.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.